Published in PLoS One on June 26, 2014
Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review. Mol Cancer (2016) 0.89
Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease. World J Biol Chem (2015) 0.87
MicroRNAs as predictive biomarkers and therapeutic targets in prostate cancer. Am J Clin Exp Urol (2014) 0.86
MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samples. Biomed Res Int (2014) 0.83
MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery. Asian J Androl (2016) 0.81
Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer. Int J Clin Exp Pathol (2015) 0.81
The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol Cancer (2017) 0.80
Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens. BMC Cancer (2016) 0.78
miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer. Transl Oncol (2016) 0.78
MicroRNA-133b inhibits cell migration and invasion by targeting matrix metalloproteinase 14 in glioblastoma. Oncol Lett (2015) 0.75
Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder. Cancer Med (2016) 0.75
miRNAs associated with prostate cancer risk and progression. BMC Urol (2017) 0.75
miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis. Biomed Res Int (2016) 0.75
Correlation between p65 and TNF-α in patients with acute myelocytic leukemia. Oncol Lett (2015) 0.75
TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer. Prostate Cancer Prostatic Dis (2017) 0.75
miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer. Oncotarget (2017) 0.75
miR-133b suppresses metastasis by targeting HOXA9 in human colorectal cancer. Oncotarget (2017) 0.75
Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy. PLoS One (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Statistical significance for genomewide studies. Proc Natl Acad Sci U S A (2003) 88.64
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A (2004) 10.99
MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol (2009) 5.92
Widespread deregulation of microRNA expression in human prostate cancer. Oncogene (2007) 5.70
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol (2003) 4.66
The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem (2008) 3.01
MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol (2009) 2.30
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol (2000) 1.89
microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget (2012) 1.83
miRNA control of tumor cell invasion and metastasis. Int J Cancer (2010) 1.79
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer (2010) 1.76
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer (2010) 1.70
Prostate cancer: 3. Individual risk factors. CMAJ (1998) 1.66
Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins. Eur Urol (2008) 1.58
Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells. Cell Death Dis (2010) 1.55
miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol (2011) 1.41
MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res (2011) 1.39
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur Urol (2010) 1.30
MiR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1alpha. J Clin Endocrinol Metab (2011) 1.28
Histone modifications as markers of cancer prognosis: a cellular view. Br J Cancer (2007) 1.26
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. Am J Pathol (2011) 1.24
High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2010) 1.23
Classifying microRNAs in cancer: the good, the bad and the ugly. Biochim Biophys Acta (2006) 1.20
miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression. Mol Cancer (2013) 1.15
Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer. Int J Clin Exp Pathol (2013) 1.04
The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis (2010) 1.00
Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer. Prostate (2011) 0.97
Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer. Korean J Urol (2011) 0.97
Current controversies in the management of biochemical failure in prostate cancer. Clin Adv Hematol Oncol (2012) 0.95
miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression. Int J Oncol (2011) 0.93
Identification of miR-133b and RB1CC1 as independent predictors for biochemical recurrence and potential therapeutic targets for prostate cancer. Clin Cancer Res (2014) 0.92
MicroRNAs and human diseases: diagnostic and therapeutic potential. Cell Tissue Res (2014) 0.89
Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer. Nat Clin Pract Urol (2007) 0.89
Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer. J Surg Res (2010) 0.86
DNA methylation and miRNA expression profiling in childhood B-cell acute lymphoblastic leukemia. Epigenomics (2010) 0.81
Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches. Int J Urol (2012) 0.81
Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse. Cancer Genet Cytogenet (2007) 0.79
MicroRNA profiling in lymphocytes and serum of tyrosinemia type-I patients. Mol Biol Rep (2013) 0.77
Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer. Prostate (2014) 0.90